April 2014 FDA Recall Drug by Caraco Pharmaceutical Laboratories, Ltd.
D-1407-2014 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Caraco Pharmaceutical Laboratories, Ltd. on April 9, 2014 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed in OH and the recall is currently terminated.

Recall Number: D-1407-2014

Reason for Recall
Lack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.
Initiated
04-09-2014
Reported
07-02-2014
Quantity
200 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Caraco Pharmaceutical Laboratories, Ltd.
Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd, Gujarat, India, NDC 47335-154-40

Batch or Lot Expiration Information

Lot# JKM7188A